CD40 and pancreatic neoplasm: Even if anti-CD40 antibodies may not only target TAM and DCs, but also other CD40-expressing cells such as endothelial cells, in combination with gemcitabine, CD40 agonists have already been shown to induce clinical responses in patients with surgically incurable pancreatic cancer (59).